1. Home
  2. AVIR vs WILC Comparison

AVIR vs WILC Comparison

Compare AVIR & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • WILC
  • Stock Information
  • Founded
  • AVIR 2012
  • WILC 1994
  • Country
  • AVIR United States
  • WILC Israel
  • Employees
  • AVIR N/A
  • WILC N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • WILC Food Distributors
  • Sector
  • AVIR Health Care
  • WILC Consumer Discretionary
  • Exchange
  • AVIR Nasdaq
  • WILC Nasdaq
  • Market Cap
  • AVIR 251.7M
  • WILC 239.1M
  • IPO Year
  • AVIR 2020
  • WILC 1997
  • Fundamental
  • Price
  • AVIR $3.09
  • WILC $17.44
  • Analyst Decision
  • AVIR Hold
  • WILC
  • Analyst Count
  • AVIR 1
  • WILC 0
  • Target Price
  • AVIR $6.88
  • WILC N/A
  • AVG Volume (30 Days)
  • AVIR 318.0K
  • WILC 8.3K
  • Earning Date
  • AVIR 03-03-2025
  • WILC 03-20-2025
  • Dividend Yield
  • AVIR N/A
  • WILC 1.15%
  • EPS Growth
  • AVIR N/A
  • WILC 69.67
  • EPS
  • AVIR N/A
  • WILC 1.11
  • Revenue
  • AVIR N/A
  • WILC $154,476,098.00
  • Revenue This Year
  • AVIR N/A
  • WILC N/A
  • Revenue Next Year
  • AVIR N/A
  • WILC N/A
  • P/E Ratio
  • AVIR N/A
  • WILC $15.69
  • Revenue Growth
  • AVIR N/A
  • WILC 6.79
  • 52 Week Low
  • AVIR $2.75
  • WILC $8.18
  • 52 Week High
  • AVIR $4.60
  • WILC $17.58
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 48.26
  • WILC 66.62
  • Support Level
  • AVIR $3.04
  • WILC $16.84
  • Resistance Level
  • AVIR $3.25
  • WILC $17.23
  • Average True Range (ATR)
  • AVIR 0.13
  • WILC 0.44
  • MACD
  • AVIR 0.01
  • WILC 0.01
  • Stochastic Oscillator
  • AVIR 54.29
  • WILC 90.00

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in the development, import, export, marketing, and distribution of a wide variety of over 650 food products worldwide. Its business segment includes import, export, marketing, and distribution of food products. The principal products in the import segment product line include Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: